GLUL and hepatocellular carcinoma: Takahashi et al. revealed that glutamine synthetase (GS) is overexpressed in more than 70% of liver tumors in TSOD mice [74], and it has also been proposed as a useful marker for the differential diagnosis of early HCC from benign hepatocellular lesions in human [75].